Partners in your Strategic Vision

CTSW attorneys draw on deep experience and business savvy to counsel clients toward their objectives. We brainstorm, strategize, and collaborate on creating solutions to move their business forward.

In all of our practice areas, every client benefits from large firm experience and a tailored team. Learn more.

Practice Areas

CTSW provides comprehensive legal and business counsel to its clients in a variety of areas, and practice specialties to help clients anticipate and avoid problems, resolve disputes and achieve their business and legal needs. We focus on understanding the diverse industries in which our clients operate. From the outset, we work closely with our clients and get to know what is important to them. We constantly reevaluate and consult with our clients at all levels – business, legal and technical – and take only those actions that advance our clients’ positions and ultimate goals.

View All Practice Areas

CTSW attorneys were trained in some of the country's largest and most prestigious firms.

In addition, almost half of our lawyers have worked in the business world, many as in-house counsel to large corporations throughout the nation. We leverage that experience with the efficiencies of small teams. Our points of difference are in our approach to client service.

Meet Our Attorneys

Recent News

April 21, 2025

CTSW Represents HubSpot Consulting Partner Aptitude 8 in Merger

CTSW represented Aptitude 8, an Elite level HubSpot Global Partner, in its combination with OBO, establishing a premier HubSpot technical consulting firm. The transaction is the latest in the firm’s work with technology services clients in a M&A matters and a range of corporate transactions and agreements. Corporate attorneys Larry Tauber, Daniel Arbov, and Russ […]

March 24, 2025

CTSW Advises Regor Pharmaceuticals (USA) in $850 Million Oncology Transaction with Genentech

CTSW represented Regor Pharmaceuticals in its sale of next-generation CDK inhibitors for breast cancer treatment to Genentech (a Roche Group member) for an upfront payment of $850 million plus milestone payments. CTSW advised on all aspects of the negotiation and transaction. We are proud to support impactful transactions driving pharmaceutical innovation.

September 21, 2022

CTSW Represents Customer Research Technology Firm in Asset Purchase by Life Sciences Commercialization Company

CTSW represented a customer research technology firm in the sale of customer research technology to a life sciences commercialization company. The transaction is the latest in CTSW’s long history of work in M&A involving technology and life sciences. Robert Boghosian, Larry Tauber, and Monica Noguera worked on this transaction.